A new clinical trial in Australia, called PLATYPUS, will simultaneously test two medications that have already been approved for other conditions in people with progressive forms of multiple sclerosis (MS).
The study, expected to launch in January, will use an adaptive design, meaning data will be analyzed as it’s available rather than waiting till the end of the study as is usually done in clinical trials. This will let researchers drop medications that aren’t producing a meaningful effect and add new ones as the trial progresses. Read more HERE…